Lexuss 210 - 23359-016-16 - (Codeine Phosphate and Chlorpheniramine Maleate)

Alphabetical Index


Drug Information of Lexuss 210

Product NDC: 23359-016
Proprietary Name: Lexuss 210
Non Proprietary Name: Codeine Phosphate and Chlorpheniramine Maleate
Active Ingredient(s): 2; 10    mg/5mL; mg/5mL & nbsp;   Codeine Phosphate and Chlorpheniramine Maleate
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of Lexuss 210

Product NDC: 23359-016
Labeler Name: Centurion Labs
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date: 20090415

Package Information of Lexuss 210

Package NDC: 23359-016-16
Package Description: 473 mL in 1 BOTTLE (23359-016-16)

NDC Information of Lexuss 210

NDC Code 23359-016-16
Proprietary Name Lexuss 210
Package Description 473 mL in 1 BOTTLE (23359-016-16)
Product NDC 23359-016
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Codeine Phosphate and Chlorpheniramine Maleate
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 20090415
Marketing Category Name UNAPPROVED DRUG OTHER
Labeler Name Centurion Labs
Substance Name CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE
Strength Number 2; 10
Strength Unit mg/5mL; mg/5mL
Pharmaceutical Classes Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]

Complete Information of Lexuss 210


General Information